Showing results (391-400 of 411) with videos related to

Sort By:
Pageof 42
Implementation Science Communications|July 22, 2024
Quantitative outcomes of a type 2 single arm hybrid effectiveness implementation pilot study for hypertension-HIV integration in BotswanaThato Moshomo, Tendani Gaolathe, Mareko Ramotsababa, et al.
Journal of Clinical Medicine|July 27, 2024
Implementation of a Co-Design Strategy to Develop a Dashboard to Support Shared Decision Making in Advanced Cancer and Chronic Kidney DiseaseVictoria Morken, Laura M Perry, Ava Coughlin, et al.
JAMA Network Open|September 6, 2022
Characteristics and Patterns of Retention in Hypertension Care in Primary Care Settings From the Hypertension Treatment in Nigeria ProgramJiancheng Ye, Ikechukwu A Orji, Abigail S Baldridge, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|January 20, 2023
Fixed-dose combination therapy-based protocol compared with free pill combination protocol: Results of a cluster randomized trialOlutobi A Sanuade, Boni M Ale, Abigail S Baldridge, et al.
Nutrients|January 8, 2023
Sodium Content and Labelling of Packaged Foods and Beverages in Nigeria: A Cross-Sectional StudyAdedayo E Ojo, Alexandra Jones, Clementina Ebere Okoro, et al.
Journal of Clinical and Translational Science|July 31, 2026
Impact evaluation of the Hypertension Treatment in Nigeria program using the Translational Science Benefits ModelGuhan Iyer, Nanna Ripiye, Ikechukwu Anthony Orji, et al.
Plos One|January 13, 2023
Stakeholder perspectives on Nigeria's national sodium reduction program: Lessons for implementation and scale-upOlutobi A Sanuade, Vanessa Alfa, Xuejun Yin, et al.
Journal of the American Medical Informatics Association : JAMIA|August 2, 2024
Shared decision-making and disease management in advanced cancer and chronic kidney disease using patient-reported outcome dashboardsDavid Cella, Maja Kuharic, John Devin Peipert, et al.
Implementation Science : IS|November 27, 2025
Implementation outcomes from the Hypertension Treatment in Nigeria program: results from a type 2 hybrid interrupted time series trialJiancheng Ye, Lisa R Hirschhorn, Abigail S Baldridge, et al.
Pageof 42